1. 2021
  2. Integrative Transkingdom Analysis of the Gut Microbiome in Antibiotic Perturbation and Critical Illness

    Haak, B. W., Argelaguet, R., Kinsella, C. M., Kullberg, R. F. J., Lankelma, J. M., Deijs, M., Klein, M., Jebbink, M. F., Hugenholtz, F., Kostidis, S., Giera, M., Hakvoort, T. B. M., de Jonge, W. J., Schultz, M. J., van Gool, T., van der Poll, T., de Vos, W. M., van der Hoek, L. M. & Wiersinga, W. J., 16 Mar 2021, In: mSystems. 6, 2, e01148-20.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. 2020
  4. Comparison of host immune responses to LPS in human using an immune profiling panel, in vivo endotoxemia versus ex vivo stimulation

    Tawfik, D. M., Lankelma, J. M., Vachot, L., Cerrato, E., Pachot, A., Wiersinga, W. J. & Textoris, J., 1 Dec 2020, In: Scientific reports. 10, 1, p. 9918 9918.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Effect of antibiotic gut microbiota disruption on LPS-induced acute lung inflammation

    Jacobs, M. C., Lankelma, J. M., Wolff, N. S., Hugenholtz, F., de Vos, A. F., van der Poll, T. & Wiersinga, W. J., 1 Nov 2020, In: PLoS ONE. 15, 11 November, e0241748.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. 2019
  7. Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans

    Haak, B. W., Lankelma, J. M., Hugenholtz, F., Belzer, C., de Vos, W. M. & Wiersinga, W. J., 2019, In: Journal of antimicrobial chemotherapy. 74, 3, p. 782-786

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Role of Toll-Like Receptor 5 (TLR5) in Experimental Melioidosis

    Birnie, E., Weehuizen, T. A. F., Lankelma, J. M., de Jong, H. K., Koh, G. C. K. W., van Lieshout, M. H. P., Roelofs, J. J. T. H., Budding, A. E., de Vos, A. F., van der Poll, T. & Wiersinga, W. J., 2019, In: Infection and immunity. 87, 8

    Research output: Contribution to journalArticleAcademicpeer-review

  9. 2018
  10. 2017
  11. Antibiotic-induced gut microbiota disruption during human endotoxemia: a randomised controlled study

    Lankelma, J. M., Cranendonk, D. R., Belzer, C., de Vos, A. F., de Vos, W. M., van der Poll, T. & Wiersinga, W. J., 2017, In: Gut. 66, 9, p. 1623-1630

    Research output: Contribution to journalArticleAcademicpeer-review

  12. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study

    Lankelma, J. M., van Vught, L. A., Belzer, C., Schultz, M. J., van der Poll, T., de Vos, W. M. & Wiersinga, W. J., 2017, In: Intensive care medicine. 43, 1, p. 59-68

    Research output: Contribution to journalArticleAcademicpeer-review

  13. Gut microbiota disruption in critically ill patients : Discussion on "Critically ill patients demonstrate large interpersonal variation of intestinal microbiota dysregulation: a pilot study"

    Iapichino, G., Lankelma, J. M. & Wiersinga, W. J., 2017, In: Intensive care medicine. 43, 5, p. 718-719

    Research output: Contribution to journalComment/Letter to the editorAcademic

Previous 1 2 Next

ID: 69338